Patterns of bronchodilator therapy in asthmatic outpatients
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Background: Bronchodilators are used to treat asthma symptoms. The administration of this therapy can be given through monotherapy or in combination to achieve the maximum therapeutic effect.
Objective: This study aimed to examine the prescribing pattern of bronchodilators in asthmatic outpatients.
Methods: A retrospective study was done by reviewing and analyzing medical records of asthmatic outpatients from January 2019 until December 2020. Data analysis was performed descriptively.
Results: In this study, bronchodilators were administered by inhalation 97.4% compared to oral routes 2.6%. Combination bronchodilator therapy showed 54.7% compared to monotherapy by 46.3%. The combination ICS/LABA budesonide/formoterol 160/4.5 mcg was the most widely used 45.7%.
Conclusion: The use of a bronchodilator was in accordance with the Global Initiative for Asthma guidelines. The route of drug administration through inhalation is more widely used than oral. Combination bronchodilators were more recommended than bronchodilator monotherapy to control asthma symptoms.
Kawamatawong T, Sangasapaviriya A, Saiphoklang N, et al. Guidelines for the management of asthma in adults: Evidence and recommendations. Asian Pac J Allergy Immunol 2022;40:1–21.
Basic health research. RISKESDAS national report. Balitbangkes publishing agency 2018.
Global initiative for asthma (GINA). Global strategy for asthma Management and Prevention. Global Initiative for Asthma 2022.
Dusser D, Ducharme FM. Safety of tiotropium in patients with asthma. Therapeutic Advances in Respiratory Disease. SAGE Publications Ltd 2019;13. DOI: https://doi.org/10.1177/1753466618824010
Kaplan A, FitzGerald JM, Buhl R, et al. Comparing LAMA with LABA and LTRA as add-on therapies in primary care asthma management. npj Primary Care Respiratory Medicine. Nat Res 2020;30. DOI: https://doi.org/10.1038/s41533-020-00205-9
Silva D, Jacinto T. Inhaled β2-agonists in asthma management: An evolving story. Breathe 2016;12:379–81. DOI: https://doi.org/10.1183/20734735.017116
Fuseini H, Newcomb DC. Mechanisms Driving Gender Differences in Asthma. Current Allergy and Asthma Reports. Current Medicine Group LLC 1 2017;17. DOI: https://doi.org/10.1007/s11882-017-0686-1
de Boer GM, Tramper-Stranders GA, Houweling L, van Zelst CM, Pouw N, Verhoeven GT, et al. Adult but not childhood onset asthma is associated with the metabolic syndrome, independent from body mass index. Respir Med 2021;188. DOI: https://doi.org/10.1016/j.rmed.2021.106603
Christiansen SC, Zuraw BL. Treatment of Hypertension in Patients with Asthma. New England J Med 2019;381:1046–57. DOI: https://doi.org/10.1056/NEJMra1800345
Hravank M, et al. Symptom Expression in Coronary Heart Disease and Revascularization Recommendations for Black and White Patients. Ame J Pub Health 2007;1701-8. DOI: https://doi.org/10.2105/AJPH.2005.084103
Papi A. A new combination therapy for asthma: Bridging the gap between effectiveness in trials and clinical practice? Respir Med 2012;106. DOI: https://doi.org/10.1016/S0954-6111(12)00462-3
Bousquet J, Boulet LP, Peters MJ, et al. Budesonide/formoterol for maintenance and relief in uncontrolled asthma vs. high-dose salmeterol/fluticasone. Respir Med 2007;101:2437–46. DOI: https://doi.org/10.1016/j.rmed.2007.07.014
Heo YA. Budesonide/Glycopyrronium/Formoterol: A Review in COPD Drugs. Adis 2021;81:1411–22. DOI: https://doi.org/10.1007/s40265-021-01562-6
Beasley R, Martinez FD, Hackshaw A, et al. Safety of long-acting β-agonists: Urgent need to clear the air remains. Eur Respir J 2009;33:3–5. DOI: https://doi.org/10.1183/09031936.00163408
Patel S, Dickinson S, Morris K, et al. A descriptive cohort study of withdrawal from inhaled corticosteroids in COPD patients. NPJ Prim Care Respir Med 2022;32. DOI: https://doi.org/10.1038/s41533-022-00288-6
Singh D, Garcia G, Maneechotesuwan K, et al. New Versus Old: The Impact of Changing Patterns of Inhaled Corticosteroid Prescribing and Dosing Regimens in Asthma Management. Advances in Therapy. Adis 2022;39:1895–914. DOI: https://doi.org/10.1007/s12325-022-02092-7
Billington CK, Penn RB, Hall IP. β2 Agonists. In: Handbook of Experimental Pharmacology. Springer New York LLC 2016;23–40. DOI: https://doi.org/10.1007/164_2016_64
Radovanovic D, Santus P, Blasi F, Mantero M. The evidence on tiotropium bromide in asthma: From the rationale to the bedside. Vol. 12, Multidisciplinary Respiratory Medicine. BioMed Central Ltd 2017. DOI: https://doi.org/10.4081/mrm.2017.244
Montuschi P, Ciabattoni G. Bronchodilating drugs for chronic obstructive pulmonary disease: Current status and future trends. J Med Chem. Ame Chemical Society 2015;58:4131–64. DOI: https://doi.org/10.1021/jm5013227
Donohue, JF et al. Efficacy and Safety of Ipratropium Bromide/Albuterol Compared with Albuterol in Patients with Moderate to Severe Asthma: a Randomized Controlled Trial. Pulmonary Med 2016;16. DOI: https://doi.org/10.1186/s12890-016-0223-3
Halpin DMG. Tiotropium in asthma: What is the evidence and how does it fit in? World Allergy Organ J. BioMed Central Ltd 2016;9. DOI: https://doi.org/10.1186/s40413-016-0119-y
Baan EJ, Hoeve CE, de Ridder M, et al. The ALPACA study: (In)Appropriate LAMA prescribing in asthma: A cohort analysis. Pulm Pharmacol Ther 2021;71. DOI: https://doi.org/10.1016/j.pupt.2021.102074
Barjaktarevic I, Kaner R, Buhr RG, Cooper CB. Bronchodilator responsiveness or reversibility in asthma and COPD - A need for clarity. Int J COPD. Dove Medical Press Ltd 2018;13:3511–3. DOI: https://doi.org/10.2147/COPD.S183736
Agusti A, Fabbri L, Lahousse L, et al. Single inhaler triple therapy (SITT) in asthma: Systematic review and practice implications. Allergy: Eur J Allergy Clin Immunology 2022;77:1105–13. DOI: https://doi.org/10.1111/all.15076
Ullah, MU et al. Role of Tiotropium as Step Up Therapy for Asthma. Journal of Rawalpindi Medical College (JRMC). 2013;17:169-71.
Klimovic S, Scurek M, Pesl M, et al. Aminophylline Induces Two Types of Arrhythmic Events in Human Pluripotent Stem Cell–Derived Cardiomyocytes. Front Pharmacol 2022;12 DOI: https://doi.org/10.3389/fphar.2021.789730
Lorensia A, Ikawati Z, Andayani TM, Maranatha D. Comparison of Improvement in Peak Expiratory Flow Values Using Aminophylline and Salbutamol in Asthma Exacerbations. Indonesia J Chest 2018;5.
Copyright (c) 2023 the Authors
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.